Day: November 7, 2024

Nyxoah Reports Third Quarter Financial and Operating Results

REGULATED INFORMATION Nyxoah Reports Third Quarter Financial and Operating Results FDA approval on track for first quarter 2025, U.S. commercial team build out in progress Company fully funded with cash until mid 2026 Mont-Saint-Guibert, Belgium – November 6, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough

Search Here

Popular News

Two Saudi Racers Secure Top Positions in Women’s Cup

Jeddah: Saudi racers Reem Al-Aboud and Yasmeen Al-Sayed secured top positions in the Women’s Cup during the first round of the 2026 Saudi Toyota Championship Time Attack, held at the Jeddah Corniche Circuit.

According to Saudi Press Agency, the res…

MENU

CATEGORIES